智通财经APP讯，万润新能(688275.SH)发布公告，2025年四季度以来，公司磷酸铁锂产线已超负荷运 转，为确保磷酸铁锂生产线安全、稳定、高效运行，自2025年12月28日起，公司将对部分产线按照预定 计划进行减产检修，预计检修时间为期一个月。本次部分产线减产检修系为保障磷酸铁锂生产线的持续 稳定运转，本次检修预计减少公司磷酸铁锂产量5000吨至2万吨，预计对公司生产经营不产生重大影 响。 ...

格隆汇12月25日｜万润新能公告，自2025年12月28日起，公司将对部分产线按照预定计划进行减产检 修，预计检修时间为期一个月。本次部分产线减产检修系为保障磷酸铁锂生产线的持续稳定运转，本次 检修预计减少公司磷酸铁锂产量5,000吨至2万吨，预计对公司生产经营不产生重大影响。 ...

公司公告汇总关于被广州期货交易所指定为碳酸锂交割厂库的公告 2024年12月10日，公司召开董事会及监事会会议，审议通过申请广州期货交易所碳酸锂指定交割厂库的 议案。2025年12月22日，广州期货交易所发布公告，新增公司为碳酸锂期货指定交割厂库。该事项有利 于结合现货市场、期货市场与交割厂库，增强公司抗风险能力与市场竞争力，对公司业务拓展和盈利水 平提升具有积极作用。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 截至2025年12月24日收盘，万润新能(688275)报收于77.35元，上涨2.11%，换手率8.7%，成交量7.36万 手，成交额5.69亿元。 当日关注点 交易信息汇总资金流向 12月24日主力资金净流出3357.05万元；游资资金净流出854.87万元；散户资金净流入4211.92万元。 来自交易信息汇总：12月24日主力资金净流出3357.05万元，散户资金净流入4211.92万元。 来自公司公告汇总：万润新能被广州期货交易所新增为碳酸锂期货指定交割厂库，有助于提升市 场竞争力和盈利水平。 ...

Core Viewpoint - Lithium prices have reached new highs, with carbonate lithium prices continuing to rise, indicating strong demand and cost pressures in the lithium battery supply chain [3][4]. Price Trends - As of December 22, the CIF price of spodumene concentrate (SC6) is between $1,250 and $1,330 per ton, averaging $1,290, which is a nearly 20% increase (17.3%) from two weeks prior [3]. - The spot price of battery-grade lithium carbonate is between 95,000 and 102,000 yuan per ton, averaging approximately 98,000 yuan, reflecting an 8% increase from two weeks ago [3]. Cost Impact on Phosphate Iron Lithium - A rise of 10,000 yuan per ton in lithium carbonate increases the cost of phosphate iron lithium cathode materials by approximately 2,300 to 2,500 yuan per ton [4]. - The current lithium carbonate prices exceed the tolerable range for downstream material companies, prompting major phosphate iron lithium manufacturers to raise processing fees starting January 2026 [4]. Price Negotiations and Market Dynamics - Domestic phosphate iron lithium manufacturers are engaged in price negotiations with downstream battery cell manufacturers, with the first round of negotiations yet to conclude for many material suppliers [4]. - The recent price increase in phosphate iron lithium is attributed to rising upstream material costs, a recovery in market demand in the second half of the year, and a structural shortage of high-end products [5]. Demand Drivers - The demand for phosphate iron lithium products is significantly increasing, particularly from the energy storage market, driven by technological advancements and supportive policies [5]. - Companies like Hunan Youneng and Wanrun New Energy report strong demand from energy storage and power battery sectors [5]. Competitive Landscape - The phosphate iron lithium industry has faced prolonged low-price competition, leading to some manufacturers accepting lower prices to secure orders from battery factories [6]. - The average price of phosphate iron lithium materials fell from 173,000 yuan per ton at the end of 2022 to 34,000 yuan per ton by August 2025, marking an 80.2% decline [6]. Industry Cost Structure - The China Chemical and Physical Power Industry Association has established an average cost range for the industry between 15,714.8 yuan and 16,439.3 yuan per ton, urging member companies to avoid low-price sales that breach cost lines [7]. - The association's recommendations aim to mitigate the adverse effects of irrational competition and ensure sustainable industry development [7]. Future Production Strategies - Phosphate iron lithium companies are adopting a cautious approach to capacity expansion, with many firms indicating a slowdown in production growth due to previous losses [8]. - Companies are focusing on technological innovation and comprehensive strength in the supply chain as key factors for future competitive dynamics [9].

Group 1 - Lithium prices have reached new highs, with lithium carbonate prices increasing by nearly 20% in two weeks, averaging around 1290 USD per ton, while battery-grade lithium carbonate prices rose by 8% to approximately 98,000 CNY per ton [1] - The rising cost of lithium carbonate, a key raw material for lithium iron phosphate (LFP), has led to increased processing fees for LFP manufacturers, with companies like Hunan Youneng raising fees by 3000 CNY per ton [2][3] - The demand for LFP products is surging, particularly in the energy storage and power battery sectors, driven by technological advancements and supportive policies [4] Group 2 - The LFP industry has faced a prolonged period of low-price competition, with prices dropping from 173,000 CNY per ton to 34,000 CNY per ton, a decline of 80.2%, resulting in continuous losses for over 36 months [3][5] - The China Chemical and Physical Power Industry Association has set an average cost range for LFP materials between 15,714.8 CNY and 16,439.3 CNY per ton, urging member companies to avoid low-price sales and to be cautious with capacity expansion [5] - Future competition in the LFP industry will increasingly depend on companies' technological innovation capabilities and overall strength in the supply chain [5]

Group 1 - The core viewpoint of the news is that Wanrun New Energy has seen a significant increase in its stock price, rising 1.98% to 77.25 yuan per share, with a total market capitalization of 9.743 billion yuan and a cumulative increase of 8.19% over three consecutive days [1] - Wanrun New Energy, established on December 24, 2010, specializes in the research, production, sales, and service of lithium battery cathode materials, with its main revenue sources being lithium iron phosphate (96.49%), by-products (2.83%), lithium phosphate (0.41%), and others (0.27%) [1] - The stock has a trading volume of 569 million yuan and a turnover rate of 8.70% [1] Group 2 - According to data, Huaxia Fund has a significant holding in Wanrun New Energy, with its Huaxia Clean Energy Leader Mixed Fund A (018918) holding 32,700 shares, accounting for 6.83% of the fund's net value, making it the third-largest holding [2] - The fund has generated a floating profit of approximately 49,100 yuan today and a total of 191,300 yuan during the three-day increase [2] - The Huaxia Clean Energy Leader Mixed Fund A was established on August 22, 2023, with a latest scale of 21.1408 million yuan and has achieved a year-to-date return of 23.57% [2]

证券代码：688275 证券简称：万润新能 公告编号：2025-046 湖北万润新能源科技股份有限公司 关于被广州期货交易所指定为碳酸锂交割厂库的公告 本公司董事会、全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 广州期货交易所于2025年12月22日发布《关于调整碳酸锂期货指定交割库的公告》（广期所发〔2025〕 431号），决定新增公司为碳酸锂期货指定交割厂库。 本次公司被广州期货交易所指定为碳酸锂交割厂库事项，有利于将现货市场、期货市场、交割厂库三者 有机结合，进一步增强公司的抗风险能力和市场竞争力，对公司未来拓展业务渠道和提高盈利水平将产 生积极作用，促进公司健康发展。 特此公告。 湖北万润新能源科技股份有限公司董事会 2025年12月24日 2024年12月10日，湖北万润新能源科技股份有限公司（以下简称"公司"）召开第二届董事会第十七次会 议、第二届监事会第十四次会议，审议通过了《关于申请广州期货交易所碳酸锂指定交割厂库的议 案》，现将有关进展公告如下： ...

Group 1 - Rhine Biotech plans to change control by acquiring 80% stake in Beijing Jinkangpu, with the current controlling shareholder transferring 60 million shares (8.09% of total shares) and relinquishing voting rights on 189 million shares (25.5% of total shares) [1][2] - The acquisition is expected to be completed after the transfer of shares and the board of directors' restructuring, making Guangzhou Defu Nutrition the new controlling shareholder [1] - The specific transaction price for the acquisition of Beijing Jinkangpu is yet to be determined, and the transaction is not expected to constitute a major asset restructuring [2] Group 2 - Shida Shenghua and Bertli are planning to list H-shares on the Hong Kong Stock Exchange, with both companies considering the interests of existing shareholders and market conditions [3] - The listing process for both companies is in discussion with relevant intermediaries, and specific details have not yet been finalized [3] Group 3 - Ningbo Huaxiang's subsidiary has signed a contract for the production of robot joints, which is expected to positively impact future operating performance starting from January 2026 [4] Group 4 - Ningbo Port plans to acquire 100% of the equity of Zhoushan Port Comprehensive Bonded Zone Terminal for 706 million yuan to resolve competition issues [7] - The company aims to enhance its operational capabilities through this acquisition [7] Group 5 - Huaxin Building Materials' major shareholder plans to increase its stake in the company by 200 to 400 million yuan within six months [12] - The shareholder has secured a loan commitment of up to 360 million yuan from a bank to facilitate this purchase [12]

Group 1 - Shareholder of Okoyi plans to reduce holdings by up to 1.89% of the company's shares, amounting to a maximum of 3 million shares due to personal funding needs [1] - Tianchuang Fashion is planning a change in control, leading to continued suspension of its stock trading, expected to last no more than 3 trading days [2] - China Electric Power Construction Company reported a new contract amount of 10,317.55 billion yuan for the first 11 months of 2025, a year-on-year decrease of 1.65% [3] Group 2 - Pilin Bio's wholly-owned subsidiary received approval for a clinical trial of a drug, indicating progress in its product development [4] - Yihong Medical obtained two medical device registration certificates for diagnostic kits, enhancing its product portfolio [5] - Aohong Electronics plans to use up to 450 million yuan of idle fundraising for cash management, targeting safe and liquid financial products [6] Group 3 - China Electric Power Construction signed a contract worth approximately 6.626 billion yuan for a natural gas booster station project in Turkey, with a construction period of about 55 months [7] - Baosheng Co. won a bid for a power cable project in Singapore, valued at around 1.2 billion yuan, marking the largest overseas order in its history [8] - *ST Xinyan's stock will resume trading on December 24, 2025, following a capital increase plan that will raise its total share capital to 3.29 billion shares [9] Group 4 - Ningbo Construction's subsidiary signed a construction contract worth 428 million yuan for an engineering project with a duration of 990 days [11] - Lianhuan Pharmaceutical's subsidiary received approval for a drug that passed the consistency evaluation for generic drugs, enhancing its market competitiveness [12] - Zhongjie Automotive received a project designation for a new electric air conditioning compressor, with expected sales of approximately 29.86 million USD over its lifecycle [13] Group 5 - Biopharmaceuticals' major shareholder plans to increase holdings by 50 million to 100 million yuan, indicating confidence in the company's future [14] - Haizheng Pharmaceutical's subsidiary received approval for a veterinary drug product, expanding its product offerings in the animal health sector [15] - *ST Songfa's subsidiary signed contracts for the construction of 8 vessels, with a total contract value between 200 million to 400 million USD [16] Group 6 - Shandong Pharmaceutical Glass announced the resignation of its chairman due to age reasons, indicating a potential leadership transition [17] - Xinno Wei's subsidiary received approval for a clinical trial of a monoclonal antibody drug, indicating advancements in its drug development pipeline [18] - Ningbo Huaxiang's subsidiary secured an order for robot joints, expected to positively impact future business performance [19][20] Group 7 - China Resources Double Crane's subsidiary received approval for a clinical trial of a drug aimed at treating a genetic eye disease, reflecting ongoing R&D efforts [21] - Huaxin Technology's shareholders set a transfer price of 56.69 yuan per share for a block of shares, indicating active shareholder engagement [22] - Xinhua Net announced the resignation of its president due to job relocation, suggesting potential changes in management [23] Group 8 - Taiji Group plans to transfer a 40% stake in a subsidiary to focus on its core pharmaceutical business, enhancing operational efficiency [24] - Huaxin Construction's shareholder plans to increase holdings by 200 million to 400 million yuan, reflecting confidence in the company's prospects [25] - Dongjie Intelligent is planning to issue shares and cash for asset acquisition, with stock trading suspended until further notice [26] Group 9 - Wanrun New Energy was designated as a delivery warehouse for lithium carbonate futures, indicating its strategic position in the market [27] - Prolo Pharmaceutical's subsidiary received a drug registration certificate for an influenza treatment, expanding its product range [28] - Saiwu Technology invested 5 million yuan in a private equity fund focused on smart vehicles and energy innovation, indicating strategic investment in growth sectors [29] Group 10 - Bohui Innovation's subsidiary received approval for a clinical trial of an immunoglobulin drug, indicating progress in its product development [30] - Bohui Innovation's subsidiary also received a drug registration certificate for a coagulation factor product, enhancing its therapeutic offerings [31] - Hanghua Co. plans to allocate 146 million yuan of surplus fundraising for a new green printing materials project, reflecting a commitment to sustainability [32] Group 11 - Nova Star Cloud obtained a loan commitment letter from a bank for a share repurchase plan, indicating financial support for its capital management strategy [33] - Jimin Health established a joint venture for technology innovation, indicating a strategic move to enhance its technological capabilities [34] - Huili Pharmaceutical received a drug registration certificate for a medication used in treating digestive ulcers, expanding its product portfolio [35]

责任编辑：山上 格隆汇12月23日丨万润新能(688275.SH)公布，广州期货交易所于2025年12月22日发布《关于调整碳酸 锂期货指定交割库的公告》（广期所发〔2025〕431号），决定新增公司为碳酸锂期货指定交割厂库。 本次公司被广州期货交易所指定为碳酸锂交割厂库事项，有利于将现货市场、期货市场、交割厂库三者 有机结合，进一步增强公司的抗风险能力和市场竞争力，对公司未来拓展业务渠道和提高盈利水平将产 生积极作用，促进公司健康发展。 股票频道更多独家策划、专家专栏，免费查阅>> ...